scientific programme
32
tuesday, 24 June 2014
PL-03
PLENARY LECTURE
09:00–09:45
Plenary Hall A
Track: Basic
Topic: Addictive disorders (A)
The endocannabinoid system–a fifty years
trip
Raphael Mechoulam, Israel
Learning Objectives:
Delegates attending this
presentation would have an improved under-
standing as to how cannabis use can contribute
to the severity of psychiatric symptoms and
cognitive decline.
S-11
SYMPOSIUM
10:00–12:00
Ballroom A
Track: Clinical
Topic: Bipolar disorder (A)
The potential of high-risk studies to in-
form early intervention in bipolar disorder
Chair:
Philip Mitchell, Australia
Co-Chair: John Nurnberger, USA
S-11-001
Use of genetic and clinical variables for clini-
cal intervention in subjects at risk for bipo-
lar disorder
John Nurnberger, USA
S-11-002
The clinical trajectory into bipolar disor-
der: Targeting early intervention in high-
risk youth
Anne Duffy, Canada
S-11-003
What interventions can be used in high risk
offspring? An evidence map of currently
available therapies, and their potential for
preventing disease onset or progression
Jan Scott, United Kingdom
S-11-004
Using brain imaging and genetics to identify
those at high risk for bipolar disorder
Philip Mitchell, Australia
G. Roberts, A. Frankland, M. Breakspear,
P. Schofield, J. Fullerton
Learning Objectives:
In this symposium del-
egates will be informed on how early interven-
tion in bipolar disorder may lead to improved
outcomes.
S-12
SYMPOSIUM
10:00–12:00
Ballroom B
Track: Translational
Topic: Schizophrenia (A)
Targeting the endocannabinoid system to
treat psychiatric disorders: Clinical and
pre-clinical evidence
Chair:
Elizabeth Scarr, Australia
Co-Chair: Brian Dean, Australia
S-12-001
CB1 receptor imaging provides a model for
evidence-based treatment development in
post-traumatic stress disorder
Alexander Neumeister, USA
S-12-002
A homeostatic role for the endocannabinoid
system in schizophrenia
F. Markus Leweke, Germany
C. Rohleder, F. Enning, F. Pahlisch, C. Schae-
fer, J. K. Mueller, M. Hellmich, D. Koethe,
J. M. Bumb
S-12-003
Cannabinoid receptors in the human CNS:
Changes in psychotic disorders
Brian Dean, Australia
S-12-004
What do CB1 knockout mice tell us about
the endocannabinoid system
Elizabeth Scarr, Australia
Learning Objectives:
This symposium will
explore findings that suggest targeting the
endocannabinoid system may be a new op-
portunity to treat psychiatric disorders.
S-13
SYMPOSIUM
10:00–12:00
Ballroom C
Track: Translational
Topic: Depression (A)
The epigenetic embedding of early life
stress in humans and animal models
Chair:
Marco Andrea Riva, Italy
Co-Chair: Moshe Szyf, Canada
S-13-001
Epigenetic signature of life adversities in
utero and long-term consequence for men-
tal illness
Marco Andrea Riva, Italy
